Skip to content
Screener

GRAIL, Inc. GRAL Return on equity

Return on equity at other companies

Abbott logo
AbbottABT
10.7%-20.4pp
Guardant Health logo
Guardant HealthGH
-438.1%-1,655pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-67.4%-16.0pp
Myriad Genetics logo
Myriad GeneticsMYGN
-76.7%-98.4pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-41.4%-6.7pp

Other financials

Income statement

See full
Revenue$44.7M+25.7%
Operating income-$173.8M-9.4%
Net income-$110.2M+3.3%
EPS (diluted)-$2.56+19.5%

Balance sheet

See full
Cash & equivalents$62.6M-52.1%
Total debt$91.3M+46.9%
Total equity$2.5B+9.9%
Total assets$2.8B+5.2%

Cash flow

See full
Operating cash flow-$80.7M-4.9%
CapEx$432.0K+17.1%
Free cash flow-$81.2M-4.9%

Valuation

See full
Market cap$2.72B+129%
Enterprise value$2.75B+145%
P/S16.5×+7.6×

Profitability

See full
Operating margin-338.4%-74.4pp
Net margin-236.9%-52.1pp
FCF margin-179.2%-46.7pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio10.9×+1.7×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054307

FAQ

What is GRAIL, Inc.'s return on equity?
GRAIL, Inc. (GRAL) reported return on equity of -16.1% in Q2 2026.
How has GRAIL, Inc.'s return on equity changed year-over-year?
GRAIL, Inc.'s return on equity increased by 8.8% year-over-year, from -17.7% to -16.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about GRAIL, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude